Daniel L. Korpolinski

Advent International LP (Advent) is an independent private equity firm founded in 1984 by Henry H. Haight. The firm is headquartered in Boston, Massachusetts.

GPC Biotech, Inc. discovers and develops anticancer drugs through discovery technologies and development approaches. It is a mechanism-based drug discovery and development company focused on treatments for cancer and fungal infections. The company is a wholly owned subsidiary of GPC Biotech AG. GPC Biotech was founded in 1992 and is located in Waltham, MA.

Bowdoin College is an independent, nonsectarian, coeducational residential, undergraduate liberal arts institution founded in 1794. It is located in Brunswick, ME.

Synthesis Capital is a venture capital firm founded in 2007. The firm is headquartered in Boston, Massachusetts.

Spear Therapeutics Ltd. develops cancer treatment drugs. The firm offers cytochrome P450 (CYP)-activated prodrugs. It designs prodrugs that are activated by enzymes that are found in cancer tissues. The company was founded by Steven A. Everett and Gerard Andrew Potter and is headquartered in Manchester, the United Kingdom.

Broadview Ventures, Inc. (Broadview Ventures) is a venture capital firm founded in 2008. The firm is headquartered in Boston, Massachusetts.

Renovacor, Inc. operates as a preclinical stage biopharmaceutical company focused on developing transformative gene therapy based treatments for cardiovascular disease. The company is headquartered in Philadelphia, PA.

Basking Biosciences, Inc. is a clinical-stage company that aims to solve the biggest need in ischemic stroke therapy. The company is based in Columbus, OH. The company is developing a first-in-class RNA aptamer targeting von Willebrand factor (vWF), an important structural component of blood clots and driver of the clotting process. Basking is also developing a complementary rapid-acting reversal oligonucleotide capable of quickly neutralizing the pharmacological activity of the RNA aptamer. The company has successfully completed a phase 1 single-ascending dose safety study and is initiating a phase 2 clinical proof-of-concept study in patients suffering from an acute ischemic stroke. The ultimate goal is to extend the therapeutic window for thrombolysis compared to currently approved therapies. Basking Biosciences was founded in 2019 by Shahid Nimjee, Bruce A. Sullenger, and Richard J. Shea has been the CEO of the company since 2019.

Technology Review, Inc. operates as a digitally oriented global media company. It equip its audiences with the intelligence to understand a world shaped by technology. The company was founded in 1899 and is headquartered in Cambridge, MA.

New England Baptist Hospital provides orthopedic surgery and the treatment of musculoskeletal diseases and disorders. Its services include orthopedics, general surgery, medical services, patient care services, and programs. The company was founded by Francis Fremont Whittier in 1893 and is headquartered in Boston, MA.

IHM Services Co. provides clinical intelligence solutions for hospitals. It offers financial stability, performance, care quality and outcomes by transforming hospital data into actionable information across the healthcare enterprise. The company is headquartered in Lowell, MA.

Lazard Healthcare Acquisition Corp. I is a blank check company, which engages in mergers, share exchanges, asset acquisitions, share purchases, and reorganizations. The company was founded on February 25, 2021 and is headquartered in New York, NY.

Galecto Biotech ApS provides galectin modulators for the treatment of severe diseases, including fibrosis and cancer. Its products include galectin-3 inhibitors, fibrosis and literature. The company was founded by Tariq Sethi, Hans Thalsgard Schambye, Ulf Jorgen Nilsson, and Hakon Leffler in 2011 and is headquartered in Copenhagen, Denmark.

Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States.

Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA.

MAP Pharmaceuticals, Inc. develops therapies and inhalation delivery technologies. The company was founded by Thomas A. Armer on July 3, 2003 and is headquartered in Irvine, CA.

Etex Corp. manufactures calcium phosphate biomaterials. Its products are used for bone graft substitutes, reconstruction of skeletal defects, orthopedic, spine indications, and orthopedic implants. The company was founded by D. Duke Lee in 1989 and is headquartered in Cambridge, MA.

ImClone LLC develops targeted biologic treatments designed for the medical needs of patients with tumors. The company was founded in 1984 and is headquartered in Bridgewater, NJ.

PharmAkea, Inc. develops small molecule drug candidates against protein targets involved in fibro proliferative diseases. It discovers and develops small molecule therapeutics directed at cancer and fibrotic diseases. The company was founded by John Howard Hutchinson, Kevin Holme, and Jilly Evans in 2012 and is headquartered in San Diego, CA.

SynGen, Inc. designs and manufactures innovative devices designed for separation and isolation of therapeutic cells. It offers products that improve the recovery, purity and viability of stem and other clinically important cells from umbilical cord blood, peripheral blood, bone marrow, and cell culture. The firms products include SynGenX-1000 System, CryoPRO-2 Bag Sets, SynGenX-LAB System, and tube welding workstation. The company was founded by Philip H. Coelho, Gabriel G. Alvarado, and George J. Barry in 1999 and is headquartered in Rancho Cordova, CA